Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser Rutland Herald
Finance, IT & News
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser Rutland Herald
FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer The Clinical Trial Vanguard
Fitch Raises Portugal’s Rating to A+ portugal decoded
Silk Road Group's credit rating outlook upgraded to positive by Moody's Telecompaper
Moody's affirms A2 rating on St. Louis airport bonds STLtoday.com